Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM: 6-Thioguanine in ALL/LBL Maintenance
NCT02912676Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tioguanine in acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL). Primary endpoint: Mean DNA-Thioguanine Nucleotide Level. Started Oct 2016; status: completed.
02
Drugs
tioguanine
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT02912676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912676.